Skolnick P - Search Results

1

An AMPA receptor potentiator modulates hippocampal expression of BDNF: an in vivo study.

Mackowiak M, O'Neill MJ, Hicks CA, Bleakman D, Skolnick P. Mackowiak M, et al. Among authors: skolnick p. Neuropharmacology. 2002 Jul;43(1):1-10. doi: 10.1016/s0028-3908(02)00066-7. Neuropharmacology. 2002. PMID: 12213254

2

LY503430, a novel alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor potentiator with functional, neuroprotective and neurotrophic effects in rodent models of Parkinson's disease.

Murray TK, Whalley K, Robinson CS, Ward MA, Hicks CA, Lodge D, Vandergriff JL, Baumbarger P, Siuda E, Gates M, Ogden AM, Skolnick P, Zimmerman DM, Nisenbaum ES, Bleakman D, O'Neill MJ. Murray TK, et al. Among authors: skolnick p. J Pharmacol Exp Ther. 2003 Aug;306(2):752-62. doi: 10.1124/jpet.103.049445. Epub 2003 May 2. J Pharmacol Exp Ther. 2003. PMID: 12730350

3

Neurotrophic actions of the novel AMPA receptor potentiator, LY404187, in rodent models of Parkinson's disease.

O'Neill MJ, Murray TK, Whalley K, Ward MA, Hicks CA, Woodhouse S, Osborne DJ, Skolnick P. O'Neill MJ, et al. Among authors: skolnick p. Eur J Pharmacol. 2004 Feb 20;486(2):163-74. doi: 10.1016/j.ejphar.2003.12.023. Eur J Pharmacol. 2004. PMID: 14975705

4

Regulation of BDNF expression in primary neuron culture by LY392098, a novel AMPA receptor potentiator.

Legutko B, Li X, Skolnick P. Legutko B, et al. Among authors: skolnick p. Neuropharmacology. 2001 Jun;40(8):1019-27. doi: 10.1016/s0028-3908(01)00006-5. Neuropharmacology. 2001. PMID: 11406193

5

Antidepressant-like actions of an AMPA receptor potentiator (LY392098).

Li X, Tizzano JP, Griffey K, Clay M, Lindstrom T, Skolnick P. Li X, et al. Among authors: skolnick p. Neuropharmacology. 2001 Jun;40(8):1028-33. doi: 10.1016/s0028-3908(00)00194-5. Neuropharmacology. 2001. PMID: 11406194

6

Binding of an AMPA receptor potentiator ([3H]LY395153) to native and recombinant AMPA receptors.

Lindén AM, Yu H, Zarrinmayeh H, Wheeler WJ, Skolnick P. Lindén AM, et al. Among authors: skolnick p. Neuropharmacology. 2001 Jun;40(8):1010-8. doi: 10.1016/s0028-3908(01)00013-2. Neuropharmacology. 2001. PMID: 11406192

7

[3H]ATPA: a high affinity ligand for GluR5 kainate receptors.

Hoo K, Legutko B, Rizkalla G, Deverill M, Hawes CR, Ellis GJ, Stensbol TB, Krogsgaard-Larsen P, Skolnick P, Bleakman D. Hoo K, et al. Among authors: skolnick p. Neuropharmacology. 1999 Dec;38(12):1811-7. doi: 10.1016/s0028-3908(99)00133-1. Neuropharmacology. 1999. PMID: 10608276

8

The antidepressant-like effects of glutamatergic drugs ketamine and AMPA receptor potentiator LY 451646 are preserved in bdnf⁺/⁻ heterozygous null mice.

Lindholm JS, Autio H, Vesa L, Antila H, Lindemann L, Hoener MC, Skolnick P, Rantamäki T, Castrén E. Lindholm JS, et al. Among authors: skolnick p. Neuropharmacology. 2012 Jan;62(1):391-7. doi: 10.1016/j.neuropharm.2011.08.015. Epub 2011 Aug 16. Neuropharmacology. 2012. PMID: 21867718

9

[3H]N-2-(4-(N-benzamido)phenyl)propyl-2-propanesulfonamide: a novel AMPA receptor potentiator and radioligand.

Zarrinmayeh H, Bleakman D, Gates MR, Yu H, Zimmerman DM, Ornstein PL, McKennon T, Arnold MB, Wheeler WJ, Skolnick P. Zarrinmayeh H, et al. Among authors: skolnick p. J Med Chem. 2001 Feb 1;44(3):302-4. doi: 10.1021/jm000462n. J Med Chem. 2001. PMID: 11462971 No abstract available.

10

Enhancement of antidepressant potency by a potentiator of AMPA receptors.

Li X, Witkin JM, Need AB, Skolnick P. Li X, et al. Among authors: skolnick p. Cell Mol Neurobiol. 2003 Jun;23(3):419-30. doi: 10.1023/a:1023648923447. Cell Mol Neurobiol. 2003. PMID: 12825836

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

469 results

Search Page

Filters